Cresco Labs (CRLB.F) Stock Overview
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
CRLB.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Cresco Labs Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.32 |
| 52 Week High | CA$2.30 |
| 52 Week Low | CA$0.43 |
| Beta | 1.73 |
| 1 Month Change | -7.69% |
| 3 Month Change | -8.33% |
| 1 Year Change | 43.95% |
| 3 Year Change | -34.98% |
| 5 Year Change | -90.22% |
| Change since IPO | -69.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| CRLB.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 10.9% | 1.6% | 0.2% |
| 1Y | 43.9% | 30.7% | 18.7% |
Return vs Industry: CRLB.F exceeded the US Pharmaceuticals industry which returned 26.7% over the past year.
Return vs Market: CRLB.F exceeded the US Market which returned 19.8% over the past year.
Price Volatility
| CRLB.F volatility | |
|---|---|
| CRLB.F Average Weekly Movement | 31.2% |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CRLB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CRLB.F's weekly volatility has increased from 21% to 31% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2,900 | Charlie Bachtell | www.crescolabs.com |
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s Edibles brand, as well as licenses the Kiva brand.
Cresco Labs Inc. Fundamentals Summary
| CRLB.F fundamental statistics | |
|---|---|
| Market cap | US$617.57m |
| Earnings (TTM) | -US$52.19m |
| Revenue (TTM) | US$661.62m |
Is CRLB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRLB.F income statement (TTM) | |
|---|---|
| Revenue | US$661.62m |
| Cost of Revenue | US$344.93m |
| Gross Profit | US$316.69m |
| Other Expenses | US$368.88m |
| Earnings | -US$52.19m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 47.87% |
| Net Profit Margin | -7.89% |
| Debt/Equity Ratio | 98.0% |
How did CRLB.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/13 10:22 |
| End of Day Share Price | 2026/01/13 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cresco Labs Inc. is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Capital Markets |
| Russell Stanley | Beacon Securities Limited |